Table 1.
Characteristics | Discordant | Accordant | P-value |
---|---|---|---|
Number of patients | 44 (25.9%) | 126 (74.1%) | - |
Age at diagnosis (years) | |||
Mean | 46.3 ± 12.8 | 49.6 ± 12.1 | 0.130 |
Median | 50.0 | 51.0 | 0.847 |
Gender | |||
Male | 30 (68.2%) | 85 (67.5%) | 0.930 |
Female | 14 (31.8%) | 41 (32.5%) | |
Preoperative KPS | |||
>70 | 36 (81.8%) | 81 (64.3%) | 0.031 |
≤ 70 | 8 (18.2%) | 45 (35.7%) | |
Extent of resection | |||
GTR | 32 (72.7%) | 64 (50.8%) | 0.012 |
Non-GTR | 12 (27.3%) | 62 (49.2%) | |
Tumor volume (cm3) | |||
Mean | 36.8 ± 33.1 | 44.5 ± 51.7 | 0.352 |
Median | 31.7 | 38.0 | 0.330 |
Ventricle infringement | |||
Yes | 23 (52.3%) | 79 (62.7%) | 0.224 |
No | 21 (47.7%) | 47 (37.3%) | |
MGMT promoter | |||
Methylated | 19 (43.2%) | 44 (35.8%) | 0.384 |
Unmethylated | 25 (56.8%) | 79 (64.2%) | |
Tumor location | |||
Frontal | 13 (29.5%) | 41 (32.5%) | 0.926 |
Temporal | 16 (36.4%) | 40 (31.7%) | |
Insular | 9 (20.5%) | 22 (17.5%) | |
Parietal | 4 (9.1%) | 16 (12.7%) | |
Occipital | 2 (4.5%) | 7 (5.6%) | |
TERT promoter | |||
Mutant | 11 (37.5%) | 49 (42.3%) | 0.080 |
Wild | 17 (62.5%) | 35 (57.7%) | |
Patterns of progression | |||
Local recurrence | 24 (54.5%) | 103 (81.7%) | 0.003 |
Distant metastasis | 9 (20.5%) | 8 (6.3%) | |
Subependymal spread | 9 (20.5%) | 11 (8.7%) | |
Leptomeningeal dissemination | 2 (4.5%) | 4 (3.2%) |
T1CE, T1 weighted contrast-enhancing images; KPS, Karnofsky Performance Status score; GTR, gross total removal of tumor; MGMT, O-6-methylguanine DNA methyltransferase. Bold: significant.